Nanobiotix

NANOFR0011341205

Nanobiotix is a biotechnology company that uses nanomedicine to develop new radiotherapy techniques for cancer patients. The company is headquartered in Paris, with additional corporate offices in New York and Massachusetts.

Filings

5 filings

All Inside information63 Voting rights and capital32 Threshold crossing29 Quarterly financial information5 Earnings release4 Annual financial report4 Universal registration document2 Tender offer2

02/06/2026
Nanobiotix Provides First Quarter 2026 Operational and Financial Update
Quarterly financial informationFR
24/11/2025
Nanobiotix Provides Third Quarter 2025 Operational and Financial Update Along With 2026 Clinical Outlook
Quarterly financial information
21/05/2025
Nanobiotix Provides First Quarter 2025 Operational and Financial Update
Quarterly financial informationFR

About

ISIN: FR0011341205
Ticker: NANO
LEI: 969500667RSYIH8YL895
Founded: 2003
Country of registration: FR
Last filing: 30/07/2026, 22:15

Wikipedia

Description from Wikidata, CC0 licence.

Filing history

Filings per month

Sept 23May 24Jan 25Sept 25Aug 26

Document types

Across the whole archive